MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-KL-13-0001060
Fling Pharmaceuticals Private Limited
Fling Pharmaceuticals Private Limited - pharma in Thrissur, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹14.1 Cr
▼ 21% YoY
Net profit · FY 2024
₹57.57 Lakh
Net margin 4.1%
EBITDA · FY 2024
₹1.43 Cr
EBITDA margin 10.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹99.8 Lakh
Issued & subscribed
Open charges
₹7.75 Cr
Satisfied ₹1.38 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
40
Provident fund records
About Fling Pharmaceuticals Private Limited
Data last updated:
Fling Pharmaceuticals Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2005PTC018835. Its GSTIN is 32AABCF0638D1ZB (Kerala).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹99.8 Lakh. It is led by directors including Madhu Karuvanchery Vijayan Nair (Managing Director) and Biju Kapplingattu Krishnan Namboodiri (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No. B1 31/441/5 First Floor Navamy Regency Sitaram Mill Road Punkunnam P.O., Thrissur, Kerala, India – 680002.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.1 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹57.57 Lakh (net margin 4.1%) and EBITDA of ₹1.43 Cr (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 9% over five years.
The company has about 40 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹7.75 Cr and satisfied charges of ₹1.38 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Fling Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-13-0001060). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232KL2005PTC018835
Registration Number 018835
Incorporation Date 18 November 2005
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-13-0001060
CIN history
Fling Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232KL2005PLC018835. The current CIN is U24232KL2005PTC018835, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232KL2005PTC018835 | Current |
| U24232KL2005PLC018835 | Previous |
Key People
Madhu Karuvanchery Vijayan Nair Managing Director Biju Kapplingattu Krishnan Namboodiri Whole-Time Director David Joseph Palayoor Whole-Time Director Recognitions & Rankings of Fling Pharmaceuticals
Contact details
Fling Pharmaceuticals Private Limited's registered office is in Thrissur, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo. B1 31/441/5 First Floor Navamy Regency Sitaram Mill Road Punkunnam P.O., Thrissur, Kerala, India – 680002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Fling Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Fling Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Fling Pharmaceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fling Pharmaceuticals Private Limited, buy the company report.
Financials of Fling Pharmaceuticals Private Limited
FY 2024 filings availableFling Pharmaceuticals Private Limited reported revenue of ₹14.1 Cr (down 21% YoY) for FY 2024.
Revenue · FY 2024
₹14.1 Cr ▼ 21%
Net profit · FY 2024
₹57.57 Lakh margin 4.1%
EBITDA · FY 2024
₹1.43 Cr margin 10.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 24%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 37%
3 years · compounded
▲ 98%
5 years · compounded
▲ 20%
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fling Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fling Pharmaceuticals Private Limited
Fling Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Karuvanchery Vijayan Nair Also directs: Sreeparna Pharmaceutical Distributors Private Limited | Managing Director | 01 Apr 2024 | 2 Years 6 Months | Current |
| Biju Kapplingattu Krishnan Namboodiri Also directs: Albus Pharmaceuticals Private Limited | Whole-Time Director | 11 Mar 2009 | 17 Years 7 Months | Current |
| David Joseph Palayoor Also directs: Variety Formulations Pvt Ltd, Ave Health Care Private Limited | Whole-Time Director | 12 May 2010 | 16 Years 5 Months | Current |
Peer comparison
Fling Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Park N Chem Pharmaceuticals Private Limited | ₹14.16 Cr (FY 2025) | -3.0% | Amritsar, Punjab, India | |||
| Aravindh Herbal Labs Private Limited | ₹14.14 Cr (FY 2025) | -2.0% | Rajapalayam, Tamil Nadu, India | |||
| Fling Pharmaceuticals Private Limitedthis company | ₹14.1 Cr (FY 2024) | ₹57.57 Lakh | 4.1% | -21.0% | 40 | Thrissur, Kerala, India |
| Okinawa Pharmaceuticals Private Limited | ₹14.1 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Microwin Labs Private Limited | ₹14.05 Cr (FY 2024) | 61.0% | Mohali, Punjab, India | |||
| Functional Health Private Limited | ₹14.04 Cr (FY 2025) | 28.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Fling Pharmaceuticals Private Limited, buy the company report.
Auditor
Fling Pharmaceuticals Private Limited is audited by KRISHNAMOORTHY & KRISHNAMOORTHY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNAMOORTHY & KRISHNAMOORTHY | FY 2023 | 001488S |
Shareholding
The shareholding of Fling Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fling Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.75 Cr
Satisfied charges
₹1.38 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Oct 2025 | 101181785 | Dhanlaxmi Bank Limited | ₹3.3 Cr | Open | |
| 08 Jan 2025 | 101040710 | Dhanlaxmi Bank Limited | ₹34 Lakh | Open | |
| 19 Aug 2024 | 101005059 | Others | ₹1.05 Cr | Open | |
| 03 Aug 2020 | 100361213 | Dhanlaxmi Bank Limited | ₹27.33 Lakh | Open | |
| 06 Oct 2018 | 100210398 | Dhanlaxmi Bank Limited | ₹32.5 Lakh | Open |
To see the full charge records of Fling Pharmaceuticals Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
Fling Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Fling Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against State of Kerala and 2 others | Disposed |
To see the full case history of Fling Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Fling Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 36 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Variety Pharmaceuticals Pvt Ltd | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Fling Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Fling Pharmaceuticals has 2 subsidiary companies and 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
2
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Variety Pharmaceuticals Pvt Ltd | U24231KL1984PTC003945 | |
| Variety Formulations Pvt Ltd | U24231KL1988PTC005228 |
To see the full group structure of Fling Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Fling Pharmaceuticals Private Limited has a workforce of 40 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
40
Active EPFO establishments
1
Employee growth
2.56%
GST
Fling Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AABCF0638D1ZB | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fling Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fling Pharmaceuticals Private Limited has 8 board changes on record since 2009: 3 appointments and 5 cessations. The latest: Madhu Karuvanchery Vijayan Nair was appointed as Managing Director on 01 Apr 2024.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 3.30 Cr with Charge ID 101181785 was registered on 04 Oct 2025.
Charges
A charge with Dhanlaxmi Bank Limited of Rs. 0.97 Cr registered on 17 Apr 2018 with Charge ID 100176290 was modified on 19 Feb 2025.
Charges
A charge registered on 22 Mar 2017 via Charge ID 100092649 with Dhanlaxmi Bank Limited was fully satisfied on 19 Feb 2025.
Charges
A charge registered on 21 Jun 2016 via Charge ID 100039504 with Dhanlaxmi Bank Limited was fully satisfied on 19 Feb 2025.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.34 Cr with Charge ID 101040710 was registered on 08 Jan 2025.
Charges
A charge registered on 19 Mar 2013 via Charge ID 10510561 with Dhanlaxmi Bank Limited was fully satisfied on 05 Nov 2024.
AGM
Fling Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.05 Cr with Charge ID 101005059 was registered on 19 Aug 2024.
Appointed
Madhu Karuvanchery Vijayan Nair was appointed as Managing Director.
Ceased
Madhusudhanan Kunnathully ceased to be Managing Director.
Filing
Fling Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
Ceased
Madhu Karuvanchery Vijayan Nair ceased to be Director.
14 earlier events are in the company report.
Frequently asked questions
Fling Pharmaceuticals is an active private limited company based in Thrissur, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2005 (21+ years old) and is registered under CIN U24232KL2005PTC018835.
Fling Pharmaceuticals has 3 current directors:
- Madhu Karuvanchery Vijayan Nair - Managing Director
- Biju Kapplingattu Krishnan Namboodiri - Whole-Time Director
- David Joseph Palayoor - Whole-Time Director
The latest financial statements of Fling Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Fling Pharmaceuticals is 32AABCF0638D1ZB, registered in Kerala.
The CIN (Corporate Identification Number) of Fling Pharmaceuticals is U24232KL2005PTC018835. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fling Pharmaceuticals has 1 court case on record: 1 filed by the company.
Fling Pharmaceuticals was incorporated on 18 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Fling Pharmaceuticals by revenue are Park N Chem Pharmaceuticals Private Limited, Aravindh Herbal Labs Private Limited, Okinawa Pharmaceuticals Private Limited, Microwin Labs Private Limited, Functional Health Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Madhu Karuvanchery Vijayan Nair was appointed as Managing Director on 01 Apr 2024. Madhusudhanan Kunnathully ceased to be Managing Director on 01 Apr 2024. Madhu Karuvanchery Vijayan Nair ceased to be Director on 05 May 2023. Fling Pharmaceuticals has 8 board changes on record in total.
Yes, Fling Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-KL-13-0001060).
Fling Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 36 overdue payments to 3 micro and small suppliers. The latest return was filed on 04 Jul 2019.
The registered office of Fling Pharmaceuticals is at No. B1 314415 First Floor Navamy Regency Sitaram Mill Road Punkunnam P.O., Thrissur, Kerala, India – 680002.